We can make gout management more successful now

Current Opinion in Rheumatology

Volumn 20, Issue 2, 2008, Pages 167-172

  Becker, Michael A ^a   Chohan, Saima ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Diagnosis and management; Evidence based management guidelines; Gout; Lifestyle and pharmacological interventions; Urate crystals; Urate lowering agents

Indexed keywords

ALLOPURINOL; ANTIGOUT AGENT; BENZBROMARONE; COLCHICINE; FEBUXOSTAT; FENOFIBRATE; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PEGLOTICASE; PROBENECID; STEROID; SULFINPYRAZONE; UNCLASSIFIED DRUG; URATE; URICOSURIC AGENT;

CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; COMPREHENSION; DISEASE COURSE; DRESS SYNDROME; DRUG COMPETITION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; GOUT; HEALTH CARE PERSONNEL; HEALTH PRACTITIONER; HIGH RISK POPULATION; HUMAN; INTERVENTION STUDY; KIDNEY FAILURE; LIFESTYLE; LIVER TOXICITY; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RASH; REVIEW; UNCERTAINTY;

EVIDENCE-BASED MEDICINE; GOUT; HUMANS; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RISK REDUCTION BEHAVIOR; URIC ACID; URICOSURIC AGENTS;

EID: 40349110730     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3282f54d03     Document Type: Review

References (44)